← Open Payments lookup

GENEVIEVE SLOBODA: Open Payments

NPI 1912994195 · ACTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,605 in 74 payments from 17 companies in 2025. Trend: 2023 $661 · 2024 $911 · 2025 $1,605

Food & beverage: $1,564Education: $41
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation23$392
Regeneron Healthcare Solutions, Inc.8$248
GlaxoSmithKline, LLC.13$228
AstraZeneca Pharmaceuticals LP7$148
Amgen Inc.4$111
GENZYME CORPORATION2$82
Lilly USA, LLC3$72
Pharming Healthcare, Inc.2$47
Takeda Pharmaceuticals U.S.A., Inc.2$44
Galderma Laboratories, L.P.2$39

Products named: DUPIXENT, NUCALA, TEZSPIRE, Rhapsido, EBGLYSS, TRELEGY ELLIPTA, XOLAIR, RUCONEST.

Industry payments across MA — which companies pay providers there.